TomoTherapy Marks Five Years of Clinical Success
Customer- and Survivor-Focused Events Highlight Monthlong
Commemoration
MADISON, Wis. (Business Wire EON) July 17, 2008 --
TomoTherapy Incorporated (NASDAQ:
TOMO) recently commemorated the fifth anniversary of the
first patient treatment on a clinical TomoTherapy®
Hi·Art®
system, which occurred July 1, 2003, at Thompson Cancer Survival Center
in Knoxville, Tenn. The commemoration began in mid-June with the annual
North America Hi·Art System Users
Meeting and Symposium on Helical TomoTherapySM.
It ended on July 12, 2008, with Radiate Hope, a fundraising event and
celebration of cancer survivorship spearheaded by TomoTherapy employees,
and sponsored by the company.
“July 1, 2003 marked a new day in cancer care,”
said Fred Robertson, CEO of TomoTherapy. “Since
that first treatment, we’ve installed more
than 200 Hi·Art systems, and customers
have delivered over one million CT-guided, intensity-modulated radiation
therapy (IMRT) fractions via our platform. In looking back at five years
of clinical acceptance and success, we wanted to honor the great work of
customers, as well as the inspiring lives of those treated with our
technology.”
To commemorate this anniversary, TomoTherapy hosted the customer- and
survivor-focused events in Madison, Wis., home to TomoTherapy
headquarters and the University of Wisconsin, where the concepts of
helical TomoTherapy were first explored and developed.
More than 100 TomoTherapy customers and guests attended the fifth annual North
America Users Meeting and Symposium on Helical TomoTherapy on
June 13 and 14, 2008. The two-day event focused on harnessing
the power of the Hi·Art platform and
highlighted its increased use for stereotactic procedures. Notable
presentations included:
-
An Liu, Ph.D., assistant professor of medical physics, City of Hope
National Medical Center, on optimizing efficiency of stereotactic
radiosurgery delivery with helical TomoTherapy;
-
Michael Bloom, R.T. (R)(T), radiation oncology manager, Memorial
Hospital Cancer Center, on his center’s use
of TomoTherapy’s stereotactic
capabilities for the treatment of lung cancer;
-
Tewfik Bichay, Ph.D., director of medical physics, Lacks Cancer
Center, St. Mary’s Health Care, on his
center’s extensive experience using the Hi·Art
system for cranial radiosurgery;
-
Mark Ritter, M.D., Ph.D., associate professor of radiation oncology,
University of Wisconsin School of Medicine and Public Health, on a
clinical trial to investigate use of the Hi·Art
system for new approaches to hypofractionated radiation therapy for
prostate cancer;
-
Ke Sheng, Ph.D., assistant professor of medical physics, University of
Virginia Health System, on accounting for target motion in
stereotactic body radiotherapy for lung tumors;
-
Craig Stevens, M.D., Ph.D., division chief of radiation oncology, H.
Lee Moffitt Cancer Center & Research Institute, on why he considers
Moffitt’s decision to purchase three Hi·Art
systems, “the best technical decision we’ve
made.”
The second annual Radiate Hope event, held on July 12, 2008,
raised more than $70,000 for cancer research and support organizations
in the Madison, Wis. area. The event attracted approximately 400
attendees for a family-focused celebration of survivorship. Eight cancer
survivors addressed the crowd, sharing the stories of their cancer
journeys and discussing how TomoTherapy’s treatment
technology has impacted their lives.
About Radiate HopeSM
Radiate Hope began as a project of the
employees of TomoTherapy Incorporated. The goal was to celebrate the
impact of their work on the lives of cancer patients, and to raise funds
for cancer awareness, education, research, and treatment assistance.
Radiate Hope was incorporated in May 2007 as a non-profit and operates
in accordance with Section 501(c)(3) of the Internal Revenue Code.
Radiate Hope Foundation is supported entirely by donations and many
volunteers throughout the Madison, Wis. community. To learn more, go to www.radiatehope.org.
About TomoTherapy Incorporated
TomoTherapy Incorporated has developed, markets and sells the TomoTherapy®
Hi·Art®
treatment system, an advanced radiation therapy system for the treatment
of a wide variety of cancers. The Hi·Art
treatment system combines integrated CT imaging with conformal radiation
therapy to deliver sophisticated radiation treatments with speed and
precision while reducing radiation exposure to surrounding healthy
tissue. The company’s stock is traded on the
NASDAQ Global Select Market under the symbol TOMO. To learn more about
TomoTherapy, please visit TomoTherapy.com.
©2008 TomoTherapy Incorporated. All rights
reserved. TomoTherapy, CTrue, the TomoTherapy logo and Hi·Art
are among trademarks, service marks or registered trademarks of
TomoTherapy Incorporated.
Post Comment:
Trackback URL: http://eon.businesswire.com/pingpr.php/RW1wdC1Mb3ZlLU1hZ24tU2luZy1TaW5nLVNpbmctWmVybw==
Bookmark -
Del.icio.us |
Digg |
Furl It |
Spurl |
RawSugar |
Simpy |
Shadows |
Blink It |
My Web
|
